Keyphrases
Non-coding
100%
Non-coding RNA (ncRNA)
100%
Antisense Oligonucleotides
100%
Gynecologic Malignancies
100%
Urinary Malignancy
100%
Universal Target
100%
Proliferating Cells
66%
Tumor Cell Lines
66%
Tumor Cells
66%
MicroRNA
66%
Apoptosis
33%
Tumor Suppressor
33%
Cell Proliferation Inhibition
33%
Cell Tumor
33%
Human Cells
33%
Cancer Biology
33%
Knockdown
33%
Kidney
33%
Prostate
33%
Prostate Cancer
33%
Poor Prognosis
33%
Bladder
33%
Cell Cycle Control
33%
Apoptotic Cell Death
33%
Invasion Factor
33%
Survivin
33%
Mitochondria
33%
DNA Fragmentation
33%
Cell Cycle Progression
33%
Control Cell
33%
Functional Role
33%
Cell Survival
33%
Xenograft Model
33%
Cell Death
33%
Nuclear Localization
33%
Antisense Transcript
33%
Cervical Cancer
33%
Inhibitor of Apoptosis Proteins
33%
Stemness
33%
Targeted Therapy
33%
Differential Expression Pattern
33%
Unmet Needs
33%
Highly Heterogeneous
33%
Strong Inhibition
33%
Bladder Cancer
33%
Cytoplasmic Localization
33%
Variable Response
33%
Cell Metastasis
33%
Long Non-coding RNA (LncRNA)
33%
Heterogeneous Groups
33%
Ovarian Cancer
33%
Aberrant Expression
33%
Caspase Activation
33%
Cervix
33%
Non-dividing Cells
33%
Host Gene
33%
Advanced Stage Disease
33%
Conventional Chemotherapy
33%
Oligonucleotide Therapeutics
33%
Kidney Cancer
33%
Human Biopsies
33%
Non-protein
33%
Antisense Oligonucleotide Therapy
33%
Urinary Tract Cancer
33%
Urological Malignancies
33%
Protein-coding Transcript
33%
MRNA Decay
33%
Mitochondrial Membrane Potential Loss
33%
Gynecological Cancer
33%
DNA Mitochondrial
33%
Migration Factor
33%
Medicine and Dentistry
In Vitro
100%
Malignant Neoplasm
100%
Antisense Oligonucleotide
100%
Cell Proliferation
100%
Programmed Cell Death
100%
Cancer
100%
Urinary System
100%
Long Untranslated RNA
100%
Tumor Cell Line
66%
Tumor Cell
66%
microRNA
66%
Prostate Cancer
33%
Xenograft
33%
Tumor Suppressor Protein
33%
Metastatic Carcinoma
33%
Bladder
33%
Disease
33%
Antisense
33%
Survivin
33%
DNA Fragmentation
33%
Cancer Pathobiology
33%
Mitochondrion
33%
Cell Death
33%
Kidney Cancer
33%
Mediator
33%
Biopsy
33%
Cell Cycle Progression
33%
Targeted Therapy
33%
Cell Survival
33%
Cell Cycle Regulation
33%
Bladder Cancer
33%
Mitochondrial Membrane Potential
33%
Cervical Cancer
33%
Antisense Therapy
33%
Caspase
33%
Ovarian Cancer
33%
Cervix
33%
Mitochondrial DNA
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
100%
Antisense Oligonucleotide
100%
Long Untranslated RNA
75%
microRNA
50%
Disease
25%
Tumor Suppressor Protein
25%
Prostate Cancer
25%
Survivin
25%
Kidney Cancer
25%
Caspase
25%
Uterine Cervix Cancer
25%
Ovary Cancer
25%
Chemotherapy
25%
Bladder Cancer
25%
Biochemistry, Genetics and Molecular Biology
Antisense
100%
Oligonucleotide
80%
Cell Proliferation
60%
Long Non-Coding RNA
60%
Tumor Suppressor Protein
20%
Messenger RNA
20%
Cell Cycle Regulation
20%
Mitochondrial Membrane Potential
20%
Mitochondrion
20%
Cell Death
20%
DNA Fragmentation
20%
Cell Cycle Progression
20%
Cell Survival
20%
Survivin
20%
Mediator
20%
Apoptosis
20%
Inhibitor of Apoptosis
20%
Caspase
20%
Immunology and Microbiology
Antisense
100%
Cell Proliferation
60%
Tumor Cell
40%
Tumor Cell Line
40%
Ovary
40%
Human Cell
20%
Xenograft
20%
Cell Death
20%
Caspase
20%
DNA Fragmentation
20%
Mitochondrion
20%
Cell Survival
20%
Mediator
20%
Cell Cycle Progression
20%
Cell Cycle Regulation
20%
Apoptosis
20%
Mitochondrial Membrane Potential
20%